Skip to Main Content

Paper Details

YTHDF2 inhibition potentiates radiotherapy antitumor efficacy.
Cancer Cell
22
2023
IR, MDSC, MDSC populations, N-methyladenosine, NF-B, RNA, YTHDF2, Ythdf2, Ythdf2 deficiency, anti-PD-L1, cancer, humans, mA, myeloid cells, myeloid-derived suppressor cell, transcripts, tumor
Author NameAffiliation
Hualiang JiangShanghai Institute of Materia Medica, Chinese Academy of Sciences
Chuan Heand Institute for Biophysical Dynamics, The University of Chicago, USA Howard Hughes Medical Institute, University of Chicago
Chuan Heand Institute for Biophysical Dynamics, The University of Chicago, USA Howard Hughes Medical Institute, University of Chicago
  • 1 - 3

Datasets

Release 1.2